Lmr Partners LLP Repligen Corp Transaction History

Lmr Partners LLP

  • $9.66 Billion
  • Q4 2024

A detailed history of Lmr Partners LLP transactions in Repligen Corp stock. As of the latest transaction made, Lmr Partners LLP holds 22,756 shares of RGEN stock, worth $3.48 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
22,756
Previous 24,167 5.84%
Holding current value
$3.48 Million
Previous $3.6 Million 8.93%
% of portfolio
0.03%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$123.41 - $160.92 $174,131 - $227,058
-1,411 Reduced 5.84%
22,756 $3.28 Million
Q3 2024

Nov 07, 2024
BUY
$119.79 - $167.35 $2.89 Million - $4.04 Million
24,167 New
24,167 $3.6 Million
Q4 2023

Feb 14, 2024
BUY
$114.17 - $185.35 $722,581 - $1.17 Million
6,329 Added 316.45%
8,329 $1.5 Million
Q3 2023

Nov 14, 2023
BUY
$138.78 - $176.51 $277,560 - $353,020
2,000 New
2,000 $318,000
Q3 2022

Nov 14, 2022
BUY
$160.42 - $256.21 $1.97 Million - $3.14 Million
12,258 Added 451.33%
14,974 $2.8 Million
Q2 2022

Aug 15, 2022
SELL
$140.68 - $188.02 $681,453 - $910,768
-4,844 Reduced 64.07%
2,716 $441,000
Q1 2022

May 16, 2022
SELL
$161.19 - $257.96 $599,787 - $959,869
-3,721 Reduced 32.98%
7,560 $1.42 Million
Q4 2021

Feb 14, 2022
SELL
$247.59 - $304.47 $2.67 Million - $3.28 Million
-10,772 Reduced 48.85%
11,281 $2.99 Million
Q3 2021

Nov 15, 2021
BUY
$194.77 - $324.21 $4.3 Million - $7.15 Million
22,053 New
22,053 $6.37 Million
Q4 2020

Feb 16, 2021
SELL
$148.08 - $206.57 $2.92 Million - $4.08 Million
-19,729 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$122.51 - $158.27 $426,457 - $550,937
-3,481 Reduced 15.0%
19,729 $2.91 Million
Q2 2020

Aug 14, 2020
BUY
$94.33 - $140.48 $2.19 Million - $3.26 Million
23,210 New
23,210 $2.87 Million

Others Institutions Holding RGEN

# of Institutions
482
Shares Held
56.3M
Call Options Held
251K
Put Options Held
458K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.48B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email